IDH1 and IDH2 mutations in pediatric acute leukemia.

IDH1 and IDH2 mutations in pediatric acute leukemia.
复制标题

DOI:
10.1038/leu.2011.133
复制
发表时间:
2011-10
期刊:
影响因子:
11.4
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

为了研究异柠檬酸脱氢酶1 (IDH1)和2 (IDH2)突变在儿童急性髓性白血病(AML)和急性淋巴性白血病(ALL)中的频率,我们对515例患者(227例AML和288例ALL)的诊断样本进行了这些基因的测序。体细胞IDH1/IDH2突变在ALL中很少见(N=1),但在AML中更常见,发生率为3.5% (IDH1 N=3和IDH2 N=5),在核型正常的AML中发生率更高(9.8%)。鉴定的IDH1突变发生在密码子132上,导致精氨酸被半胱氨酸(N=3)或组氨酸(N=1)取代。相比之下,IDH2的突变不影响同源残基,但改变了密码子140,导致精氨酸被谷氨酰胺(N=4)或色氨酸(N=1)取代。IDH2的结构模型表明,密码子140突变破坏了该酶结合底物异柠檬酸盐的能力。因此,重组IDH2 R140Q/W无法将异柠檬酸脱羧为α-酮戊二酸酯(α-KG),而获得了将α-KG还原为R(−)-2-羟基戊二酸酯(2-HG)的新形态活性。对原发性白血病细胞的分析证实,IDH1/IDH2突变的aml中2-HG水平较高。有趣的是,3/5的IDH2突变AMLs具有FLT3激活突变,这提高了这些突变在白血病发生中的协同作用的可能性。
To investigate the frequency of isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) mutations in pediatric acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL), we sequenced these genes in diagnostic samples from 515 patients (227 AMLs and 288 ALLs). Somatic IDH1/IDH2 mutations were rare in ALL (N=1), but were more common in AML, occurring in 3.5% (IDH1 N=3 and IDH2 N=5), with the frequency higher in AMLs with a normal karyotype (9.8%). The identified IDH1 mutations occurred in codon 132 resulting in replacement of arginine with either cysteine (N=3) or histidine (N=1). By contrast, mutations in IDH2 did not affect the homologous residue but instead altered codon 140, resulting in replacement of arginine with either glutamine (N=4) or tryptophan (N=1). Structural modeling of IDH2 suggested that codon 140 mutations disrupt the enzyme's ability to bind its substrate isocitrate. Accordingly, recombinant IDH2 R140Q/W were unable to carry out the decarboxylation of isocitrate to α-ketoglutarate (α-KG), but instead gained the neomorphic activity to reduce α-KG to R(−)-2-hydroxyglutarete (2-HG). Analysis of primary leukemic blasts confirmed high levels of 2-HG in AMLs with IDH1/IDH2 mutations. Interestingly, 3/5 AMLs with IDH2 mutations had FLT3 activating mutations, raising the possibility that these mutations cooperate in leukemogenesis.
DOI: 10.1038/nature08617
发表时间: 2009-12-10
期刊: Nature
影响因子: 64.8
作者:
通讯作者: --
DOI: 10.1016/j.ccr.2010.11.015
发表时间: 2010-12-14
期刊: Cancer cell
影响因子: 50.3
作者:
Figueroa ME;Abdel-Wahab O;Lu C;Ward PS;Patel J;Shih A;Li Y;Bhagwat N;Vasanthakumar A;Fernandez HF;Tallman MS;Sun Z;Wolniak K;Peeters JK;Liu W;Choe SE;Fantin VR;Paietta E;Löwenberg B;Licht JD;Godley LA;Delwel R;Valk PJ;Thompson CB;Levine RL;Melnick A
通讯作者: Melnick A
DOI: 10.1182/blood.v99.12.4326
发表时间: 2002-06-15
期刊: BLOOD
影响因子: 20.3
作者:
Thiede, C;Steudel, C;Illmer, T
通讯作者: Illmer, T
DOI: 10.1074/jbc.m207306200
发表时间: 2002-11-08
影响因子: 4.8
作者:
Ceccarelli, C;Grodsky, NB;Bahnson, BJ
通讯作者: Bahnson, BJ
DOI: 10.1200/jco.2010.28.3762
发表时间: 2010-08-01
影响因子: 45.3
作者:
Paschka, Peter;Schlenk, Richard F.;Doehner, Konstanze
通讯作者: Doehner, Konstanze